Moreover, we demonstrate that AEP inhibition in BC cells sensitizes them to chemotherapeutic reagents such as cisplatin or etoposide, revealing AEP as a promising therapeutic target for the treatment of radioresistant BC patients. The gene discussed is LGMN; the disease is breast cancer.